Applications Of Bio - Systems Engineering !
Artificial Heart
Artificial lungs
Artificial kidneys
Artificial nose
Artificial tongue
Advantages & Disadvantages
Health Risks
ARTIFICIAL ORGANS.
We discussed a Brief History and Introduction of Artificial Organs.
We also discussed the Various Manufacturing Process and Application of Artificial Organs and finally we discussed the Pros and Cons of Artificial Organs.
The document discusses tissue engineering and artificial skin. It describes how the first artificial skin was invented using collagen fibers and sugar molecules to form a porous material resembling skin. It also outlines the structure of human skin and importance of skin. The key developments in artificial skin are explained, including using a small skin sample to grow enough skin to cover the body in 3 weeks. The document details the methods used to produce artificial skin, including using mesh scaffolds or collagen gels with fibroblasts and keratinocytes to form layers resembling skin. Future developments aim to produce fully functional lab-grown skin grafts.
This document summarizes a seminar presentation on tissue engineering. It defines tissue engineering as using cells, biomaterials, and biochemical factors to develop biological substitutes that restore or maintain tissue function. It discusses cells, stem cells, tissues, and provides examples of tissue engineering applications including bioartificial livers and pancreases. The presentation focuses on the bioengineering approach to creating a bioartificial pancreas using islets of Langerhans cells to secrete insulin in response to glucose levels. Key design challenges are keeping the cells alive and protected from the immune system while allowing for nutrient exchange.
This document provides an overview of the field of tissue engineering. It defines tissue engineering as an interdisciplinary field that applies engineering and life science principles toward the development of biological substitutes that restore or improve tissue function. The key goals of tissue engineering are to repair, replace, or regenerate tissues and whole organs. Current clinical treatments involve grafting methods like autografts, allografts, and xenografts, but these have limitations like immune rejection and donor scarcity. Tissue engineering aims to address these issues by using scaffolds, cells, and growth factors to regenerate tissues. Challenges in the field include properly mimicking the tissue microenvironment, scaling up production, and developing vascularization within engineered tissues.
The document discusses bioreactors used in tissue engineering. It defines bioreactors as devices that closely control conditions for cells and tissues. There are two main types of bioreactor culture systems - static and dynamic. Static systems simply culture cells in dishes while dynamic systems like rotating wall vessel bioreactors, spinner flask bioreactors, and perfusion bioreactors enhance mass transfer and mimic physiological fluid flow using stirred media. The document concludes that bioreactor design must consider the specific tissue needs and that applying mechanical forces in novel bioreactor systems can better develop functional engineered tissues.
ARTIFICIAL ORGANS.
We discussed a Brief History and Introduction of Artificial Organs.
We also discussed the Various Manufacturing Process and Application of Artificial Organs and finally we discussed the Pros and Cons of Artificial Organs.
The document discusses tissue engineering and artificial skin. It describes how the first artificial skin was invented using collagen fibers and sugar molecules to form a porous material resembling skin. It also outlines the structure of human skin and importance of skin. The key developments in artificial skin are explained, including using a small skin sample to grow enough skin to cover the body in 3 weeks. The document details the methods used to produce artificial skin, including using mesh scaffolds or collagen gels with fibroblasts and keratinocytes to form layers resembling skin. Future developments aim to produce fully functional lab-grown skin grafts.
This document summarizes a seminar presentation on tissue engineering. It defines tissue engineering as using cells, biomaterials, and biochemical factors to develop biological substitutes that restore or maintain tissue function. It discusses cells, stem cells, tissues, and provides examples of tissue engineering applications including bioartificial livers and pancreases. The presentation focuses on the bioengineering approach to creating a bioartificial pancreas using islets of Langerhans cells to secrete insulin in response to glucose levels. Key design challenges are keeping the cells alive and protected from the immune system while allowing for nutrient exchange.
This document provides an overview of the field of tissue engineering. It defines tissue engineering as an interdisciplinary field that applies engineering and life science principles toward the development of biological substitutes that restore or improve tissue function. The key goals of tissue engineering are to repair, replace, or regenerate tissues and whole organs. Current clinical treatments involve grafting methods like autografts, allografts, and xenografts, but these have limitations like immune rejection and donor scarcity. Tissue engineering aims to address these issues by using scaffolds, cells, and growth factors to regenerate tissues. Challenges in the field include properly mimicking the tissue microenvironment, scaling up production, and developing vascularization within engineered tissues.
The document discusses bioreactors used in tissue engineering. It defines bioreactors as devices that closely control conditions for cells and tissues. There are two main types of bioreactor culture systems - static and dynamic. Static systems simply culture cells in dishes while dynamic systems like rotating wall vessel bioreactors, spinner flask bioreactors, and perfusion bioreactors enhance mass transfer and mimic physiological fluid flow using stirred media. The document concludes that bioreactor design must consider the specific tissue needs and that applying mechanical forces in novel bioreactor systems can better develop functional engineered tissues.
This document discusses various applications of tissue culture, including intracellular studies, elucidation of intracellular processes, studies of cell-cell interactions, and evaluation of environmental interactions. It also notes that animal cell culture can be used to produce medically important proteins like interferon, blood clotting factors, and monoclonal antibodies. Major developments in cell culture technology included the use of antibiotics, trypsin to subculture cells, and chemically defined culture media. Common cell culture media include Eagle's Minimum Essential Medium, Dulbecco's Modified Eagle's Medium, and RPMI-1640.
Tissue engineering involves using scaffolds, cells, and biomolecules to create functional 3D tissues. It aims to develop biological substitutes to restore tissue function and repair damaged tissues, avoiding problems with organ transplants, mechanical devices, and surgery. A major goal is designing scaffolds that recreate the in vivo microenvironment through biophysical and biochemical signaling. Stem cells are a promising cell source for their ability to integrate into tissues and secrete growth factors. Signaling molecules can also be used to modulate cell behavior. Magnetic targeting of stem cells may help with the challenge of cell retention in tissue engineering applications like cardiac repair.
The document provides instructions for setting up a cell culture laboratory, including key considerations like budget, space, and equipment. It discusses necessary rooms and areas like media preparation, culture, dissection/sterilization, storage, and lists important equipment such as CO2 incubators, biosafety cabinets, centrifuges, microscopes, and PCR machines. It also provides details on setting up and maintaining specific areas and equipment.
A bio-artificial liver (BAL) is a device that combines blood filtration systems to remove toxins with hepatic cells or tissue to temporarily support patients with liver failure until a transplant can occur. It works extracorporeally to help the liver regenerate and keep the patient alive. However, BALs only provide temporary support and face challenges in acquiring enough viable hepatocytes, managing cell stress, and achieving sufficient liver function within their volume constraints until whole organ transplants can be performed.
Artificial skin is a collagen scaffold that induces regeneration of skin in mammals such as humans. The term was used in the late 1970s and early 1980s to describe a new treatment for massive burns.
This document provides an overview of tissue engineering. It discusses the process of tissue engineering which involves using a scaffold material, seeding it with living cells, using growth factors, and implanting the new tissue. It also describes different types of stem cells, materials used for scaffolds, and methods to synthesize tissue engineered scaffolds. Applications of tissue engineering include bioartificial organs and tissues like skin, bone, and blood vessels. Both advantages and disadvantages of the field are mentioned.
Tissue engineering involves using cells, biomaterials, and suitable factors to engineer biological tissues and potentially whole organs. It combines principles of engineering and life sciences towards developing tissue substitutes that can restore, maintain, or improve tissue function. Key aspects include extracting cells like stem cells, seeding them onto biodegradable scaffolds that provide a template for new tissue growth, and using bioreactors to condition the developing tissues. Potential applications include growing skin, cartilage, bone, and other tissues for regenerative medicine purposes.
The document discusses tissue engineering approaches for the nervous system. It begins with an introduction to the anatomy and limited regenerative capacity of the central and peripheral nervous systems. For peripheral nerve injuries, the current gold standard treatment is autologous nerve grafts, but these have limitations. Alternative approaches discussed include the use of nerve guides containing matrices and scaffolds to bridge gaps and guide axon regeneration. Factors like scaffold composition and geometry, inclusion of cells and growth factors, and degradation properties can influence how well scaffolds support regeneration across critical gaps in nerves. The document reviews considerations for scaffold and matrix design and various strategies for incorporating growth-promoting components in peripheral nerve engineering.
This document discusses regenerative medicine and tissue engineering. It outlines examples of regeneration in nature and clinical needs where regeneration could help such as heart disease and bone fractures. Stem cells are described as a potential cell source along with factors like growth factors and scaffold materials. Challenges in tissue engineering like optimal cell delivery and scaffold design are covered. Cardiovascular applications are discussed in depth as a promising target for regenerative approaches.
Biomaterials for tissue engineering slideshareBukar Abdullahi
An overview of Tissue Engineering with some basics in Biomaterials and Synthetic Polymers. Further references should be considered as I presented this a specific target audience.
This document provides an overview of cardiac tissue engineering. It discusses the use of biomaterials like scaffolds and hydrogels to support cells for growing new cardiac tissue. Common cell types used include stem cells and differentiated cardiac cells. Tissue engineered constructs aim to be biocompatible, functional and living to replace damaged heart tissue like blood vessels, heart valves, and myocardial patches. Recent developments include engineered tissues that closely mimic heart muscle mechanics and biology.
Tissue engineering uses scaffolds, cells, and signaling molecules to regenerate tissues and organs. Scaffolds provide a structure for cell attachment, growth, and tissue formation. Natural polymers like collagen and hyaluronic acid, and synthetic polymers like poly-lactic-co-glycolic acid are commonly used as scaffold materials. Scaffolds can be fabricated using various methods including freeze drying, electrospinning, 3D printing, and textile technologies to produce scaffolds with desirable properties like porosity and pore size for tissue growth. Scaffolds seeded with stem cells or tissue-specific cells aim to repair and regenerate tissues for applications in skin, bone, cartilage, and other organs.
Biomaterials were defined as “any substance, other than a drug, or a combination of substances, synthetic or natural in origin, which can be used for any period of time, as a whole or as a part of a system, which treats, augments or replaces any tissue, organ or function of the body”
Artificial skin is a synthetic substitute for human skin that is grown from donor skin cells in a laboratory process. It is needed to treat severe burns and skin damage by replacing lost skin. The process involves taking a small skin sample and growing fibroblasts in roller bottles for 3-4 weeks. The fibroblasts are then seeded onto biodegradable polymer scaffolds in bioreactors, where they grow and form new skin tissue over 3-4 weeks as the polymer dissolves. Keratinocytes are then added to form the epidermis, and the new skin is stored until needed for skin grafts. The polymer scaffolds support cell growth and tissue formation before being absorbed by the body, leaving only the new skin.
Introduction.
Properties of Stem Cells.
Key Research events.
Embryonic Stem Cell.
Stem cell Cultivation.
Stem cells are central to three processes in an organism.
Research & Clinical Application of stem cell.
Research patents.
Conclusion.
Reference.
Organs on a chip are multichannel 3D microfluidic cell culture chips that simulate the activities, mechanisms, and physiological responses of entire human organs. These chips recreate the smallest functional units of organs in a microenvironment mimicking the human body. Organs on chip can replace animal models in pharmaceutical research by allowing studies of drug interactions, pathogen responses, and toxicity testing in human organ systems. This technology is expected to help accelerate drug development and discovery.
Transgenic manipulation of animal embryos and its applicationDeveshMachhi
INTRODUCTION
Genetic manipulation in animal for higher productivity is also called genetic engineering, refer to the alteration of the gene of an organism.
Organisms containing integrated sequences of cloned dna (transgenes), transferred using techniques of genetic engineering (to include those of gene transfer and gene substitution) are called transgenic animals.
Transgenic technology has led to the development of fishes, live stock and other animals with altered genetic profiles which are useful to mankind.Genetically modified animals are proving ever more vital in the development of new treatments and cures for many serious diseases.
Transgenesis is a radically new technology for altering the characteristics of animals by introducing the foreign genetic material.
CONTACT: devmac1323@gmail.com
The document discusses artificial cartilage, including its history, manufacturing processes, applications, and ongoing research. It provides an overview of cartilage anatomy and notes that artificial cartilage aims to restore smooth joint surfaces and relieve symptoms. Recent developments include its use in treating knee injuries through implantation and allograft transplantation. Ongoing research focuses on more efficient regeneration methods using stem cells. The primary applications are for treating knee injuries and defects, though it can also be used in other joints.
1. Tissue engineering involves growing tissues or organs in vitro to replace damaged body parts. Cells are seeded onto a scaffold and bathed in growth factors to grow new tissue.
2. Common scaffolds include collagen, polymers like PLLA, and ceramics. Cells used include stem cells, keratinocytes for skin, and bladder cells.
3. The process involves obtaining cells, seeding them onto a scaffold, and incubating the construct to grow new tissue which can then be implanted.
Tissue engineering involves growing tissues or organs by seeding cells onto biodegradable scaffolds. There are several key steps in the tissue engineering process: (1) cells are isolated from a patient and cultured, (2) the cells are seeded onto a scaffold to allow adhesion and growth, (3) the seeded scaffolds may be placed in a bioreactor to mimic the body's conditions and stimulate growth, (4) the engineered tissues are implanted into the patient. Bioreactors help distribute cells throughout the scaffold and provide mechanical and chemical cues to influence cell behavior.
Dr. Jan Wojcicki is an expert in artificial organ research, particularly related to artificial pancreas and diabetes treatment. He has over 30 years of experience in this field and has authored over 300 publications. His research has focused on developing new monitoring technologies to improve diabetes therapy and patient outcomes. As an expert in the field, he will now serve as co-editor of Eastern Europe for the journal Artificial Organs to provide guidance and promote artificial organ research in the region.
The document discusses the history and types of artificial hearts. There are three main types: ventricular artificial heart, ventricular assist device, and total artificial heart. The total artificial heart, such as the AbioCor, consists of implanted components like the replacement heart and batteries, as well as external components like a battery bag. The artificial heart replaces the pumping function of the natural heart and requires a power source to operate. While artificial hearts can extend lives, there are still obstacles to widespread acceptance and use.
This document discusses various applications of tissue culture, including intracellular studies, elucidation of intracellular processes, studies of cell-cell interactions, and evaluation of environmental interactions. It also notes that animal cell culture can be used to produce medically important proteins like interferon, blood clotting factors, and monoclonal antibodies. Major developments in cell culture technology included the use of antibiotics, trypsin to subculture cells, and chemically defined culture media. Common cell culture media include Eagle's Minimum Essential Medium, Dulbecco's Modified Eagle's Medium, and RPMI-1640.
Tissue engineering involves using scaffolds, cells, and biomolecules to create functional 3D tissues. It aims to develop biological substitutes to restore tissue function and repair damaged tissues, avoiding problems with organ transplants, mechanical devices, and surgery. A major goal is designing scaffolds that recreate the in vivo microenvironment through biophysical and biochemical signaling. Stem cells are a promising cell source for their ability to integrate into tissues and secrete growth factors. Signaling molecules can also be used to modulate cell behavior. Magnetic targeting of stem cells may help with the challenge of cell retention in tissue engineering applications like cardiac repair.
The document provides instructions for setting up a cell culture laboratory, including key considerations like budget, space, and equipment. It discusses necessary rooms and areas like media preparation, culture, dissection/sterilization, storage, and lists important equipment such as CO2 incubators, biosafety cabinets, centrifuges, microscopes, and PCR machines. It also provides details on setting up and maintaining specific areas and equipment.
A bio-artificial liver (BAL) is a device that combines blood filtration systems to remove toxins with hepatic cells or tissue to temporarily support patients with liver failure until a transplant can occur. It works extracorporeally to help the liver regenerate and keep the patient alive. However, BALs only provide temporary support and face challenges in acquiring enough viable hepatocytes, managing cell stress, and achieving sufficient liver function within their volume constraints until whole organ transplants can be performed.
Artificial skin is a collagen scaffold that induces regeneration of skin in mammals such as humans. The term was used in the late 1970s and early 1980s to describe a new treatment for massive burns.
This document provides an overview of tissue engineering. It discusses the process of tissue engineering which involves using a scaffold material, seeding it with living cells, using growth factors, and implanting the new tissue. It also describes different types of stem cells, materials used for scaffolds, and methods to synthesize tissue engineered scaffolds. Applications of tissue engineering include bioartificial organs and tissues like skin, bone, and blood vessels. Both advantages and disadvantages of the field are mentioned.
Tissue engineering involves using cells, biomaterials, and suitable factors to engineer biological tissues and potentially whole organs. It combines principles of engineering and life sciences towards developing tissue substitutes that can restore, maintain, or improve tissue function. Key aspects include extracting cells like stem cells, seeding them onto biodegradable scaffolds that provide a template for new tissue growth, and using bioreactors to condition the developing tissues. Potential applications include growing skin, cartilage, bone, and other tissues for regenerative medicine purposes.
The document discusses tissue engineering approaches for the nervous system. It begins with an introduction to the anatomy and limited regenerative capacity of the central and peripheral nervous systems. For peripheral nerve injuries, the current gold standard treatment is autologous nerve grafts, but these have limitations. Alternative approaches discussed include the use of nerve guides containing matrices and scaffolds to bridge gaps and guide axon regeneration. Factors like scaffold composition and geometry, inclusion of cells and growth factors, and degradation properties can influence how well scaffolds support regeneration across critical gaps in nerves. The document reviews considerations for scaffold and matrix design and various strategies for incorporating growth-promoting components in peripheral nerve engineering.
This document discusses regenerative medicine and tissue engineering. It outlines examples of regeneration in nature and clinical needs where regeneration could help such as heart disease and bone fractures. Stem cells are described as a potential cell source along with factors like growth factors and scaffold materials. Challenges in tissue engineering like optimal cell delivery and scaffold design are covered. Cardiovascular applications are discussed in depth as a promising target for regenerative approaches.
Biomaterials for tissue engineering slideshareBukar Abdullahi
An overview of Tissue Engineering with some basics in Biomaterials and Synthetic Polymers. Further references should be considered as I presented this a specific target audience.
This document provides an overview of cardiac tissue engineering. It discusses the use of biomaterials like scaffolds and hydrogels to support cells for growing new cardiac tissue. Common cell types used include stem cells and differentiated cardiac cells. Tissue engineered constructs aim to be biocompatible, functional and living to replace damaged heart tissue like blood vessels, heart valves, and myocardial patches. Recent developments include engineered tissues that closely mimic heart muscle mechanics and biology.
Tissue engineering uses scaffolds, cells, and signaling molecules to regenerate tissues and organs. Scaffolds provide a structure for cell attachment, growth, and tissue formation. Natural polymers like collagen and hyaluronic acid, and synthetic polymers like poly-lactic-co-glycolic acid are commonly used as scaffold materials. Scaffolds can be fabricated using various methods including freeze drying, electrospinning, 3D printing, and textile technologies to produce scaffolds with desirable properties like porosity and pore size for tissue growth. Scaffolds seeded with stem cells or tissue-specific cells aim to repair and regenerate tissues for applications in skin, bone, cartilage, and other organs.
Biomaterials were defined as “any substance, other than a drug, or a combination of substances, synthetic or natural in origin, which can be used for any period of time, as a whole or as a part of a system, which treats, augments or replaces any tissue, organ or function of the body”
Artificial skin is a synthetic substitute for human skin that is grown from donor skin cells in a laboratory process. It is needed to treat severe burns and skin damage by replacing lost skin. The process involves taking a small skin sample and growing fibroblasts in roller bottles for 3-4 weeks. The fibroblasts are then seeded onto biodegradable polymer scaffolds in bioreactors, where they grow and form new skin tissue over 3-4 weeks as the polymer dissolves. Keratinocytes are then added to form the epidermis, and the new skin is stored until needed for skin grafts. The polymer scaffolds support cell growth and tissue formation before being absorbed by the body, leaving only the new skin.
Introduction.
Properties of Stem Cells.
Key Research events.
Embryonic Stem Cell.
Stem cell Cultivation.
Stem cells are central to three processes in an organism.
Research & Clinical Application of stem cell.
Research patents.
Conclusion.
Reference.
Organs on a chip are multichannel 3D microfluidic cell culture chips that simulate the activities, mechanisms, and physiological responses of entire human organs. These chips recreate the smallest functional units of organs in a microenvironment mimicking the human body. Organs on chip can replace animal models in pharmaceutical research by allowing studies of drug interactions, pathogen responses, and toxicity testing in human organ systems. This technology is expected to help accelerate drug development and discovery.
Transgenic manipulation of animal embryos and its applicationDeveshMachhi
INTRODUCTION
Genetic manipulation in animal for higher productivity is also called genetic engineering, refer to the alteration of the gene of an organism.
Organisms containing integrated sequences of cloned dna (transgenes), transferred using techniques of genetic engineering (to include those of gene transfer and gene substitution) are called transgenic animals.
Transgenic technology has led to the development of fishes, live stock and other animals with altered genetic profiles which are useful to mankind.Genetically modified animals are proving ever more vital in the development of new treatments and cures for many serious diseases.
Transgenesis is a radically new technology for altering the characteristics of animals by introducing the foreign genetic material.
CONTACT: devmac1323@gmail.com
The document discusses artificial cartilage, including its history, manufacturing processes, applications, and ongoing research. It provides an overview of cartilage anatomy and notes that artificial cartilage aims to restore smooth joint surfaces and relieve symptoms. Recent developments include its use in treating knee injuries through implantation and allograft transplantation. Ongoing research focuses on more efficient regeneration methods using stem cells. The primary applications are for treating knee injuries and defects, though it can also be used in other joints.
1. Tissue engineering involves growing tissues or organs in vitro to replace damaged body parts. Cells are seeded onto a scaffold and bathed in growth factors to grow new tissue.
2. Common scaffolds include collagen, polymers like PLLA, and ceramics. Cells used include stem cells, keratinocytes for skin, and bladder cells.
3. The process involves obtaining cells, seeding them onto a scaffold, and incubating the construct to grow new tissue which can then be implanted.
Tissue engineering involves growing tissues or organs by seeding cells onto biodegradable scaffolds. There are several key steps in the tissue engineering process: (1) cells are isolated from a patient and cultured, (2) the cells are seeded onto a scaffold to allow adhesion and growth, (3) the seeded scaffolds may be placed in a bioreactor to mimic the body's conditions and stimulate growth, (4) the engineered tissues are implanted into the patient. Bioreactors help distribute cells throughout the scaffold and provide mechanical and chemical cues to influence cell behavior.
Dr. Jan Wojcicki is an expert in artificial organ research, particularly related to artificial pancreas and diabetes treatment. He has over 30 years of experience in this field and has authored over 300 publications. His research has focused on developing new monitoring technologies to improve diabetes therapy and patient outcomes. As an expert in the field, he will now serve as co-editor of Eastern Europe for the journal Artificial Organs to provide guidance and promote artificial organ research in the region.
The document discusses the history and types of artificial hearts. There are three main types: ventricular artificial heart, ventricular assist device, and total artificial heart. The total artificial heart, such as the AbioCor, consists of implanted components like the replacement heart and batteries, as well as external components like a battery bag. The artificial heart replaces the pumping function of the natural heart and requires a power source to operate. While artificial hearts can extend lives, there are still obstacles to widespread acceptance and use.
This document discusses 3D bioprinting and its potential applications. It begins with definitions of bioprinting and discusses its goals in tissue engineering. Current achievements are summarized, including the first 3D printed bladder in 2006 and liver in 2009. Requirements for organ bioprinting are outlined, including cell sources, scaffold materials, and bioprinting technologies. The document concludes that bioprinting has potential to help address the shortage of organs for transplantation.
Este documento presenta los resultados de una investigación sobre órganos artificiales realizada por estudiantes. Explora cómo se fabrican estos órganos y hasta dónde puede llegar su desarrollo. Describe varios órganos artificiales existentes como corazones mecánicos, piel artificial y retinas artificiales. Aunque los órganos artificiales ofrecen esperanza para quienes necesitan un trasplante, todavía enfrentan desafíos como la posibilidad de rechazo y su madurez prematura.
1. The document discusses the history and state of artificial organs, including artificial hearts, pancreases, livers, and other applications.
2. It describes technologies like total artificial hearts, which replace both ventricles of the natural heart, and discusses how they can extend life for patients awaiting transplants.
3. While artificial organs can save lives, many challenges remain regarding device durability, infection risk, and long-term patient outcomes. Researchers continue working to develop more effective and reliable artificial organ technologies.
An artificial heart is a mechanical device that replaces a failing heart. It has several valves and chambers to propel blood through the body. Artificial hearts can temporarily assist a recovering heart or permanently replace a damaged heart until transplant. Research is ongoing to reduce artificial heart sizes and develop implantable batteries and biologically compatible materials. Artificial heart valves also help damaged valves and come in mechanical and animal tissue forms, each with advantages and disadvantages. Future areas of research include polymer and tissue engineered valves.
The document describes the design of an artificial heart called the AbioCor. It discusses the need for heart substitutes due to the large number of patients needing heart transplants. The AbioCor uses a hydraulic pump powered by an internal battery to pump blood to the lungs and body, mimicking the function of the human heart. Its design aims to meet criteria such as providing adequate blood flow, preventing blood clots and immune responses, and having a self-contained system without external wires.
The document discusses the history and development of artificial hearts. It describes early artificial heart designs from the 1950s-1980s that had limited success due to issues like foreign body rejection and limited patient mobility. More recent artificial heart designs from the 1990s onward have had improved outcomes, with some patients living over 30 days. Current challenges include reducing blood clotting and infection risks. Researchers are working on new designs using flexible plastic and a patient's own cells to potentially eliminate the need for anticoagulation drugs. The artificial heart's future relies on designs allowing worldwide mobility without complications.
The document discusses the history and development of total artificial hearts (TAH) as a treatment for end-stage heart failure. It outlines how TAHs serve as a bridge to transplantation for patients waiting on donor organs. Several TAH devices are described, including the Jarvik 7, SynCardia, AbioCor, and CardioWest models. The document also notes some limitations of TAHs but that they provide a viable alternative for patients in need of heart transplants.
The total artificial heart aims to provide an alternative treatment for patients with end-stage heart failure who are waiting for a heart transplant. It functions as an extra set of ventricles to take over the pumping function of a failing heart. While early attempts at artificial hearts were unsuccessful, advances in design have allowed some patients to survive for over 100 days or even have their own hearts heal without need for a transplant. However, artificial hearts still have disadvantages like size limitations, need to be tethered to external drivers, and risk of complications. Researchers continue working to improve artificial heart technology.
Dr. Robert Jarvik invented the artificial heart in the 1970s to help patients suffering from heart disease. The artificial heart works as a replacement for a failing heart by pumping blood through the body. It made America's list of greatest inventions because it extended many lives by giving patients more time until a heart transplant could be performed.
The document discusses biomaterials, which are materials used in medical applications that interact with biological systems. It defines biomaterials and outlines their history, characteristics, examples of applications like implants and grafts, challenges, and future potential. Key biomaterial properties include biocompatibility, mechanical compatibility with tissues, and ability to perform specific functions. Common biomaterials are metals, ceramics, polymers, and composites used in devices like heart valves, dental implants, and orthopedic implants.
An artificial heart is a prosthetic device that replaces all or part of the biological heart by duplicating its pumping function. There are three main types: ventricular assist devices, which support one ventricle; ventricular artificial hearts, which replace one ventricle; and total artificial hearts, which replace the entire heart. The AbioCor is the first self-contained total artificial heart. It consists of implanted components like the replacement heart and controller, and external components like a transcutaneous energy transmitter and batteries to power the system and allow mobility. The artificial heart must receive continuous power to pump blood, which it gets either from being plugged into a console or from a portable external battery pack.
Background of organ transplant infrastructure in the US. Some history. Definitions. Nursing Care of the transplant patient in hospital, and home settings. Intended for senior level nursing students in an ADN program
Biomaterials are any substances used in medical devices and implants that interact with biological systems. They include metals, ceramics, polymers, and composites. Biomaterials must be biocompatible and not elicit negative host tissue responses. Newer generations of biomaterials aim to regenerate tissues through cell-material interactions and tissue engineering approaches. The biomaterials field involves many disciplines working to develop safer and more effective materials for applications such as orthopedic and dental implants, vascular grafts, drug delivery devices, and more. Key challenges include replicating complex tissue structures in vitro and improving biocompatibility.
Artificial organs like artificial hearts can replace failing organs and save lives. There are two main types - ventricular assist devices that help with pumping and total artificial hearts that completely replace the heart. While they currently only last up to a year, research aims to make them more durable and accessible. Artificial hearts and future artificial organs may give people more time with loved ones and a better quality of life through technological advances. However, risks still include device failure, infection, and blood clotting complications. Continued research could lead to artificial organs being longer lasting and available to more people in need of organ transplants.
El documento resume la evolución de la tecnología en la medicina a través de la historia. Describe algunos avances clave como los rayos X en 1895, el primer uso de un microscopio en una cirugía en 1921, el riñón artificial en 1942, y el modelo de ADN de doble hélice en 1953. También discute varias clasificaciones de tecnologías médicas e identifica procesos como la innovación, investigación, y desarrollo que han impulsado nuevos avances.
The document discusses the history and components of artificial noses. It describes how artificial noses were first conceptualized in 1982 and developed in 2008. The key components are a sample delivery system, detection systems using sensors like metal oxide semiconductors, and a computing system. Different types of sensors are explained, along with applications in quality control and future prospects like medical diagnostics and security screening. In conclusion, the artificial nose is presented as a useful analytical tool that can perform repetitive detection tasks better than humans.
Biodefense; anew option against terrorism atacksemaes1_1
He presents an option for the rapid diagnosis of the microorganisms that they can find in a biological assault, similar to the antrax, vibrium cholerae, etc...
This document provides an overview of different whale species that live in the ocean. It begins with an introduction and table of contents, then provides 1-2 paragraph descriptions of 9 whale types: sperm whale, blue whale, gray whale, humpback whale, beluga whale, right whale, orca, and includes a short poem about whales at the end. The summaries highlight key identifying features and behaviors of each whale species.
This document discusses artificial organs and tissue engineering. It provides examples of artificial organs that are currently being developed or used, such as artificial hearts, lungs, kidneys, and more sensory organs like tongues and noses. The document outlines the process of tissue engineering, including extracting cells, using scaffolds, and implanting engineered tissues. Both artificial organs and tissue engineering can extend lives but have health risks, though tissue engineering may provide more biocompatible replacements.
This project report summarizes research on organ-on-a-chip technology for drug development. Organ-on-a-chip devices mimic human organs using microfluidic cell culture chips containing living cells on a small scale. Lung, heart, liver and other organ chips have been developed. The goal is a "human on a chip" with multiple organ systems to better model drug efficacy and toxicity before human trials. This technology could reduce animal testing while providing more accurate models for drug development. However, challenges remain in fully integrating multiple organ systems on a single device.
Artificial heart has provided a viable option for patient awaiting heart transplantation. Future developments on artificial hearts have the hope of eliminating the need for the transplantation completely.
The document discusses how analyzing digital photographs of patients' retinas can help diagnose and predict risk for systemic diseases. Abnormalities in the tiny blood vessels of the retina have been linked to diseases like hypertension, heart disease, stroke and diabetes. Conditions like heart disease, diabetes and others often cause anomalous changes in the retinal tissue that appear as red dots, blood clots or hemorrhages. Since the eyes are transparent, examining the retina allows physicians to directly see blood vessels in a non-invasive way. A good eye exam may help identify potential health issues.
Artificial Organ Technology and Market Analysis 2017 Report by Yole Developpe...Yole Developpement
How will artificial organs revolutionize organ transplants and overcome shortages in the next 20 years?
FIVE OUT OF THE TEN LEADING CAUSES OF DEATH IN THE WORLD WILL BENEFIT FROM ARTIFICIAL ORGANS
Organ transplantation is often the only treatment for end-state organ failure, such as liver, kidney and heart failure. Tragically, most people on the waiting list die before they ever get an organ. Hence the dream of developing artificial organs made of electronic and mechanical parts has been around for decades. The first total artificial heart transplant was in the 1980s, yet since then few improvements have made these devices more efficient. Newcomers such as Carmat and Bivacor are aiming to change the paradigm from a single mechanical heart towards a smarter solution, with embedded sensors and intelligence.
The next wave of development came from the diabetes epidemic that affects every country, hitting more than 8% of the global population today. The artificial pancreas market will therefore experience a huge 49% compound annual growth rate (CAGR) over the next five years, to reach $1.3B in 2022. The next breakthrough to happen will come in 5-10 years, bringing artificial lungs and kidneys. The first commercially approved devices will be wearable systems such as the Wearable Artificial Kidney Foundation, Inc. (WAKFI) system.
More information on that report at http://www.i-micronews.com/reports.html
Current and Future Research of E Nose(Electronic Nose)Nadiya Mahjabin
Abstract:-- Over last decade electronic sensing or e-sensing becomes an important
technology from both of technical and commercial point of view which refers to the
capability of reproducing human senses using sensor arrays and pattern recognition
system. An electronic nose is such an instrument which consists of mechanism for
identification of chemical detection such as an array of electronic sensors and a
mechanism of pattern recognition. This paper highlights the significant researches of
Electronic nose which are being performed currently and at the same time how can we
use it in the future more effectively .
Patient Safety And Human Factors Engineering Spring2006Carolyn Jenkins
1) Human Factors Engineering (HFE) uses principles to identify and control patient safety hazards by designing systems that fit human capabilities and limitations.
2) A study redesigning a Patient Controlled Analgesia pump found the new design reduced errors by 55% and completion time by an average of 18% compared to the original design.
3) HFE considers the whole healthcare system, including training, documentation, environment, and how users interact with equipment, rooms and facilities.
Day one conference projects with journey mapsDayOne
DayOne Conference 2019 projects and journey maps. 30 ventures presented their solutions and together with conference participants built a journey map of their future.
Organs on a chip are multichannel 3D microfluidic cell culture chips that simulate the activities, mechanisms, and physiological responses of entire human organs. These chips recreate the smallest functional units of organs in a microenvironment mimicking the human body. Organs on chip can replace animal models in pharmaceutical research by allowing studies of drug interactions, pathogen attacks, and toxicity testing in human organ systems. This technology is expected to help accelerate drug development and discovery.
Opto Circuits (India) Ltd produces a range of medical devices including [1] pulse oximeters to measure blood oxygen levels and pulse rate used in operating theaters and ICUs, [2] multiparameter monitors to monitor vital signs such as ECG, blood pressure, temperature and oxygen levels in ICUs, and [3] pulse oximeter sensors that interface between patients and monitoring systems, including disposable and reusable sensors. The company also produces [4] digital thermometers as an alternative to mercury thermometers, [5] cholesterol monitors to measure cholesterol levels, [6] fluid warmers to warm IV fluids, and [7] coronary stents to clear blocked arteries.
Medical Devices Used to Treat Heart ConditionsEMMAIntl
EMMA International celebrates February in recognition of American Heart Association Month and we bring you an interesting blog on the 8 types of medical devices that perform heart-related element monitoring and essential actions in case of heart-related diseases.
The first device on the list is automated external defibrillators (AEDs). These are portable devices, and they are extremely vital in cases of cardiac arrest. The major functionalities of an AED include detecting and analyzing an electrocardiogram and delivering an electric shock to normalize the heartbeat rhythm. An example of AED is Philips Medical System’s HeartStart Home device...
Prosthetic devices are artificial substitutes used to replace missing body parts. This document discusses the definition of prosthetic devices, their history, types, materials used, design characteristics, and advanced technologies. It provides details on myoelectric prosthetics which use electrical signals from muscles to power artificial limbs. Regulations for medical devices in India are also outlined, with the CDSCO and DCGI serving as the main regulatory bodies. Prosthetics aim to restore lost functions and mobility to improve patients' quality of life.
Background on the 30 projects pitching at the DayOne Conference on 9th September 2019. At the conference the projects will be assisted by mentors and conference participants to create a journey map to help them on their path to healthcare innovation.
Dr. Michael Savic is a renowned expert in signal processing who holds a patent for computer aided diagnosis of lung disease using modified stethoscopes and computer analysis of sound signals. The technology has the potential to accurately diagnose various lung diseases but the market has been slow to adopt more innovative solutions. However, demand is rising for products that can help address gaps between high-cost solutions and current electronic stethoscopes. The patented technology could see market success if licensed to emerging players developing digital stethoscopes integrated with diagnostic software applications.
Bioelectronic medicine uses principles of electronics, biology, and neuroscience to develop technologies that can diagnose diseases and regulate biological processes through nerve stimulation and sensing. This includes using implanted devices powered by the body that can replace organ functions like pacemakers for the heart or provide prosthetics for limbs. Applications also include biosensors that can monitor things like body temperature, stress, and movement to provide health and performance data. The field holds promise for new treatments for conditions like heart disease by providing electrical alternatives to drugs or surgery.
EE Disruptive Technologies in Healthcare Dec2015Padmaja Krishnan
The document discusses several disruptive technologies that have the potential to transform healthcare, including point-of-care devices that lower testing costs, smart contact lenses to monitor glucose levels, organ-on-chip technology to test drugs, 3D printed tissues and organs, and digestible sensors that monitor the body and transmit health data wirelessly. These technologies could enable cheaper, more efficient care and personalized medicine by testing treatments directly on human cells and tissues instead of animals. The document argues that healthcare industry leaders should embrace disruptive innovations to evolve healthcare delivery and enable lower costs, instead of trying to prevent disruption.
This document discusses various electronic equipment used in hospitals. It describes monitors like cardiac monitors, which display heart rate and rhythm, and digital sphygmomanometers, which measure blood pressure digitally. Electrocardiographs are discussed, which record the heart's electrical activity through electrodes. Powered medical equipment like electronic beds that adjust positions are also covered. The document concludes that electronic equipment has improved patient and doctor comfort while reducing diagnosis time.
Biomechanical engineering applies principles of mechanical engineering to biology and medicine. This includes studying areas like thermodynamics, fluid mechanics, and solid mechanics. Applications include surgical implants, prosthetics, medical devices, and tissue engineering. Advancements include the artificial heart, which functions as a bridge to transplant, artificial lungs still in development, and cochlear implants that have given deafness to over 188,000 people. These applications and advancements have improved and extended many lives.
Brain-computer interfaces and lab-grown body parts have the potential to significantly benefit society. Brain-computer interfaces can help those who have lost motor function by allowing them to control devices with their thoughts. Lab-grown body parts are being developed using methods like bioprinting, stem cells, and decellularization which could address the shortage of organs for transplant. While these technologies are still being researched, they may one day restore independence for many and potentially save thousands of lives each year.
The document discusses mobile health and open source software. It covers topics like personal health records, mobile operating systems, sensors, open hardware, social games and health, virtual and augmented reality, the Internet of Things, and nanotechnology, microtechnology, and organic, human, and ubiquitous scales in health. It also provides information on pacemakers, their evolution, and other similar devices like implantable cardiac defibrillators and deep brain stimulators.
Similar to Applications of Bio systems Engineering (Artificial Organs) (20)
Immersive Learning That Works: Research Grounding and Paths ForwardLeonel Morgado
We will metaverse into the essence of immersive learning, into its three dimensions and conceptual models. This approach encompasses elements from teaching methodologies to social involvement, through organizational concerns and technologies. Challenging the perception of learning as knowledge transfer, we introduce a 'Uses, Practices & Strategies' model operationalized by the 'Immersive Learning Brain' and ‘Immersion Cube’ frameworks. This approach offers a comprehensive guide through the intricacies of immersive educational experiences and spotlighting research frontiers, along the immersion dimensions of system, narrative, and agency. Our discourse extends to stakeholders beyond the academic sphere, addressing the interests of technologists, instructional designers, and policymakers. We span various contexts, from formal education to organizational transformation to the new horizon of an AI-pervasive society. This keynote aims to unite the iLRN community in a collaborative journey towards a future where immersive learning research and practice coalesce, paving the way for innovative educational research and practice landscapes.
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...Leonel Morgado
Current descriptions of immersive learning cases are often difficult or impossible to compare. This is due to a myriad of different options on what details to include, which aspects are relevant, and on the descriptive approaches employed. Also, these aspects often combine very specific details with more general guidelines or indicate intents and rationales without clarifying their implementation. In this paper we provide a method to describe immersive learning cases that is structured to enable comparisons, yet flexible enough to allow researchers and practitioners to decide which aspects to include. This method leverages a taxonomy that classifies educational aspects at three levels (uses, practices, and strategies) and then utilizes two frameworks, the Immersive Learning Brain and the Immersion Cube, to enable a structured description and interpretation of immersive learning cases. The method is then demonstrated on a published immersive learning case on training for wind turbine maintenance using virtual reality. Applying the method results in a structured artifact, the Immersive Learning Case Sheet, that tags the case with its proximal uses, practices, and strategies, and refines the free text case description to ensure that matching details are included. This contribution is thus a case description method in support of future comparative research of immersive learning cases. We then discuss how the resulting description and interpretation can be leveraged to change immersion learning cases, by enriching them (considering low-effort changes or additions) or innovating (exploring more challenging avenues of transformation). The method holds significant promise to support better-grounded research in immersive learning.
Current Ms word generated power point presentation covers major details about the micronuclei test. It's significance and assays to conduct it. It is used to detect the micronuclei formation inside the cells of nearly every multicellular organism. It's formation takes place during chromosomal sepration at metaphase.
Unlocking the mysteries of reproduction: Exploring fecundity and gonadosomati...AbdullaAlAsif1
The pygmy halfbeak Dermogenys colletei, is known for its viviparous nature, this presents an intriguing case of relatively low fecundity, raising questions about potential compensatory reproductive strategies employed by this species. Our study delves into the examination of fecundity and the Gonadosomatic Index (GSI) in the Pygmy Halfbeak, D. colletei (Meisner, 2001), an intriguing viviparous fish indigenous to Sarawak, Borneo. We hypothesize that the Pygmy halfbeak, D. colletei, may exhibit unique reproductive adaptations to offset its low fecundity, thus enhancing its survival and fitness. To address this, we conducted a comprehensive study utilizing 28 mature female specimens of D. colletei, carefully measuring fecundity and GSI to shed light on the reproductive adaptations of this species. Our findings reveal that D. colletei indeed exhibits low fecundity, with a mean of 16.76 ± 2.01, and a mean GSI of 12.83 ± 1.27, providing crucial insights into the reproductive mechanisms at play in this species. These results underscore the existence of unique reproductive strategies in D. colletei, enabling its adaptation and persistence in Borneo's diverse aquatic ecosystems, and call for further ecological research to elucidate these mechanisms. This study lends to a better understanding of viviparous fish in Borneo and contributes to the broader field of aquatic ecology, enhancing our knowledge of species adaptations to unique ecological challenges.
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...Sérgio Sacani
Context. With a mass exceeding several 104 M⊙ and a rich and dense population of massive stars, supermassive young star clusters
represent the most massive star-forming environment that is dominated by the feedback from massive stars and gravitational interactions
among stars.
Aims. In this paper we present the Extended Westerlund 1 and 2 Open Clusters Survey (EWOCS) project, which aims to investigate
the influence of the starburst environment on the formation of stars and planets, and on the evolution of both low and high mass stars.
The primary targets of this project are Westerlund 1 and 2, the closest supermassive star clusters to the Sun.
Methods. The project is based primarily on recent observations conducted with the Chandra and JWST observatories. Specifically,
the Chandra survey of Westerlund 1 consists of 36 new ACIS-I observations, nearly co-pointed, for a total exposure time of 1 Msec.
Additionally, we included 8 archival Chandra/ACIS-S observations. This paper presents the resulting catalog of X-ray sources within
and around Westerlund 1. Sources were detected by combining various existing methods, and photon extraction and source validation
were carried out using the ACIS-Extract software.
Results. The EWOCS X-ray catalog comprises 5963 validated sources out of the 9420 initially provided to ACIS-Extract, reaching a
photon flux threshold of approximately 2 × 10−8 photons cm−2
s
−1
. The X-ray sources exhibit a highly concentrated spatial distribution,
with 1075 sources located within the central 1 arcmin. We have successfully detected X-ray emissions from 126 out of the 166 known
massive stars of the cluster, and we have collected over 71 000 photons from the magnetar CXO J164710.20-455217.
The technology uses reclaimed CO₂ as the dyeing medium in a closed loop process. When pressurized, CO₂ becomes supercritical (SC-CO₂). In this state CO₂ has a very high solvent power, allowing the dye to dissolve easily.
The ability to recreate computational results with minimal effort and actionable metrics provides a solid foundation for scientific research and software development. When people can replicate an analysis at the touch of a button using open-source software, open data, and methods to assess and compare proposals, it significantly eases verification of results, engagement with a diverse range of contributors, and progress. However, we have yet to fully achieve this; there are still many sociotechnical frictions.
Inspired by David Donoho's vision, this talk aims to revisit the three crucial pillars of frictionless reproducibility (data sharing, code sharing, and competitive challenges) with the perspective of deep software variability.
Our observation is that multiple layers — hardware, operating systems, third-party libraries, software versions, input data, compile-time options, and parameters — are subject to variability that exacerbates frictions but is also essential for achieving robust, generalizable results and fostering innovation. I will first review the literature, providing evidence of how the complex variability interactions across these layers affect qualitative and quantitative software properties, thereby complicating the reproduction and replication of scientific studies in various fields.
I will then present some software engineering and AI techniques that can support the strategic exploration of variability spaces. These include the use of abstractions and models (e.g., feature models), sampling strategies (e.g., uniform, random), cost-effective measurements (e.g., incremental build of software configurations), and dimensionality reduction methods (e.g., transfer learning, feature selection, software debloating).
I will finally argue that deep variability is both the problem and solution of frictionless reproducibility, calling the software science community to develop new methods and tools to manage variability and foster reproducibility in software systems.
Exposé invité Journées Nationales du GDR GPL 2024
The binding of cosmological structures by massless topological defectsSérgio Sacani
Assuming spherical symmetry and weak field, it is shown that if one solves the Poisson equation or the Einstein field
equations sourced by a topological defect, i.e. a singularity of a very specific form, the result is a localized gravitational
field capable of driving flat rotation (i.e. Keplerian circular orbits at a constant speed for all radii) of test masses on a thin
spherical shell without any underlying mass. Moreover, a large-scale structure which exploits this solution by assembling
concentrically a number of such topological defects can establish a flat stellar or galactic rotation curve, and can also deflect
light in the same manner as an equipotential (isothermal) sphere. Thus, the need for dark matter or modified gravity theory is
mitigated, at least in part.
The debris of the ‘last major merger’ is dynamically youngSérgio Sacani
The Milky Way’s (MW) inner stellar halo contains an [Fe/H]-rich component with highly eccentric orbits, often referred to as the
‘last major merger.’ Hypotheses for the origin of this component include Gaia-Sausage/Enceladus (GSE), where the progenitor
collided with the MW proto-disc 8–11 Gyr ago, and the Virgo Radial Merger (VRM), where the progenitor collided with the
MW disc within the last 3 Gyr. These two scenarios make different predictions about observable structure in local phase space,
because the morphology of debris depends on how long it has had to phase mix. The recently identified phase-space folds in Gaia
DR3 have positive caustic velocities, making them fundamentally different than the phase-mixed chevrons found in simulations
at late times. Roughly 20 per cent of the stars in the prograde local stellar halo are associated with the observed caustics. Based
on a simple phase-mixing model, the observed number of caustics are consistent with a merger that occurred 1–2 Gyr ago.
We also compare the observed phase-space distribution to FIRE-2 Latte simulations of GSE-like mergers, using a quantitative
measurement of phase mixing (2D causticality). The observed local phase-space distribution best matches the simulated data
1–2 Gyr after collision, and certainly not later than 3 Gyr. This is further evidence that the progenitor of the ‘last major merger’
did not collide with the MW proto-disc at early times, as is thought for the GSE, but instead collided with the MW disc within
the last few Gyr, consistent with the body of work surrounding the VRM.
Phenomics assisted breeding in crop improvementIshaGoswami9
As the population is increasing and will reach about 9 billion upto 2050. Also due to climate change, it is difficult to meet the food requirement of such a large population. Facing the challenges presented by resource shortages, climate
change, and increasing global population, crop yield and quality need to be improved in a sustainable way over the coming decades. Genetic improvement by breeding is the best way to increase crop productivity. With the rapid progression of functional
genomics, an increasing number of crop genomes have been sequenced and dozens of genes influencing key agronomic traits have been identified. However, current genome sequence information has not been adequately exploited for understanding
the complex characteristics of multiple gene, owing to a lack of crop phenotypic data. Efficient, automatic, and accurate technologies and platforms that can capture phenotypic data that can
be linked to genomics information for crop improvement at all growth stages have become as important as genotyping. Thus,
high-throughput phenotyping has become the major bottleneck restricting crop breeding. Plant phenomics has been defined as the high-throughput, accurate acquisition and analysis of multi-dimensional phenotypes
during crop growing stages at the organism level, including the cell, tissue, organ, individual plant, plot, and field levels. With the rapid development of novel sensors, imaging technology,
and analysis methods, numerous infrastructure platforms have been developed for phenotyping.
Applications of Bio systems Engineering (Artificial Organs)
1. Artificial Organs
By,
Dineesha Nipunajith.
The Man –Made “Bridges” To Continued Life
1
2. Presentation Flow
What Is An Artificial Organ?
Artificial Heart
Artificial Lungs
Artificial Kidneys
Artificial Tongue
Artificial Nose
What are the Advantages and Disadvantages
of Artificial Organs
Health Risks
References
2
3. What Is An Artificial Organ ?
An artificial organ is a man-made device that is implanted or
integrated into a human to replace a natural organ, for the purpose of
restoring a specific function or a group of related functions so the
patient may return to a normal life as soon as possible.
Usually made out of stem cells from the patient.
3
4. Artificial Heart
Used for patients with heart failure awaiting heart transplant
Two types used:
1). Ventricle Assist Device (V.A.D).
2). Total Artificial Heart (T.A.H).
Ventricle Assist Device (V.A.D) Total Artificial Heart (T.A.H)
4
5. Ventricle Assist Device (V.A.D).
Ventricle assist device (V.A.D)
Used to help partially working ventricles of heart
Example:
NovaCare LVAS
How it works: Pump connected to left ventricle.
When heart pumps, bloods enters from left ventricle through inflow
conduit and into artificial heart pump. Low resistance from blood
moving out of the left ventricle reduces load greatly allowing heart to
have normal stroke volume. Blood in pump then leaves through an
outflow conduit and into arterial system of body.
5
6. Total Artificial Heart (T.A.H).
Total Artificial Heart(T.A.H)
Replaces both ventricles of an almost completely failed heart
attached to upper chamber of heart (left and right atrium)
Two types: Cardio west and Abiocor
6
8. Artificial Lungs
Still in development and testing
Example: Biolung
How it works: can sized lung attached to right ventricle of heart.
When blood is pumped through CO2 leaves blood and O2 enters as
blood passes through array of microfibers. Blood travels back to left
atrium of heart.
Improvements needed: Determine optimal fiber shape, distance of fibers
and number of fibers.
8
9. Artificial Kidneys
Kidney cleanses blood of waste products
Kidney/renal failure causes kidneys to not function properly, leads to
abnormal concentration of fluids within body
Kidney transplant needed in order to survive.
Artificial kidney/dialyzer used to keep patient alive while he/she waits
Dialyzer contains several small tubes and microscopic holes
Contains special fluid known as dialysate
9
10. Dialysis
Blood enters dialyzer with dialysate
Waste products move from blood to dialysate
Certain chemicals from dialysate enrich blood
Blood leaves dialyzer goes through air bubble detector and back into
bloodstream
10
11. Artificial Tongue / Electronic tongues
Chemical compound responsible for taste are detected by human taste
receptors, and the seven sensors of electronic instruments detect the
same dissolved organic and inorganic compounds.
Like human receptors, each sensor has a spectrum of reactions different
from the other. The information given by each sensor is complementary
and the combination of all sensors' results generates a unique fingerprint.
Most of the detection thresholds of sensors are similar to or better than
those of human receptors.
Input
GAS
11
12. Applications
Electronic tongues have several applications in various industrial areas:
the Pharmaceutical industry, food and beverage sector, etc. It can be used to:
analyze flavor ageing in beverages (for instance fruit juice, alcoholic or
non alcoholic drinks, flavored milks…)
quantify bitterness or “spicy level” of drinks or dissolved compounds (e.g.
bitterness measurement and prediction of teas)
quantify taste masking efficiency of formulations (tablets, syrups, powders,
capsules, lozenges…)
analyze medicines stability in terms of taste
benchmark target products.
12
13. Artificial Nose / Electronic Nose
An electronic nose is a device intended to detect odors or flavors.
Over the last decade, "electronic sensing" or "e-sensing" technologies have
undergone important developments from a technical and commercial point of view.
The expression "electronic sensing" refers to the capability of reproducing human
senses using sensor arrays and pattern recognition systems.
Since 1982, research has been conducted to develop technologies, commonly
referred to as electronic noses, that could detect and recognize odors and flavors.
The stages of the recognition process are similar to human olfaction and are
performed for identification, comparison, quantification and other applications,
including data storage and retrieval.
However, hedonic evaluation is a specificity of the human nose given that it is
related to subjective opinions. These devices have undergone much development
and are now used to fulfill industrial needs.
13
14. Applications
The fields of health and security
- The detection of dangerous and harmful bacteria, such as software that has been specifically
developed to recognize the smell of the MRSA (Methicillin-resistant Staphylococcus
Aureus).
In quality control laboratories
- Detection of contamination, spoilage, adulteration
- Conformity of raw materials, intermediate and final products
- Monitoring of storage conditions.
In process and production departments
- Cleaning in place monitoring
- Managing raw material variability
The field of crime prevention and security
- The ability of the electronic nose to detect odorless chemicals makes it ideal for use in the
police force, such as the ability to detect drug odors despite other airborne odors capable of
confusing police dogs.
- It may also be used as a bomb detection method in airports.
14
16. What are the Advantages and Disadvantages of
Artificial Organs ?
Only one major advantage, extends life increasing chance of
receiving organ transplant.
Disadvantage: Cost, artificial heart costs between $100000 to
$300000
16
17. Health Risks
Bio artificial organs have a possible presence of disease if the tissue
that was used to create the organ has been infected
Death, disabling injury, stroke, foreign body rejection, infection,
device malfunction, cognitive impairment, and weakening over time
are potential complications among completely artificial organs (heart
mortality rate: 14-27%)
Artificial hearts are only able to sustain life for up to 18 months at a
time
17
18. References
http://www.kidney.org/patients/plu/plu_online_images/hemodiagram.jpg
http://digitalmarsh.files.wordpress.com/2008/09/abiocor-heart.jpg
http://www.jdrf.org/images/General_Images/Research/art_pancreas01.jpg
http://media.rd.com/rd/images/rdc/mag0803/medical-breakthrough-BioLung-af.jpg
http://www.medgadget.com/archives/img/131113.jpg
http://www.worldheart.com/images/product-vas.jpg
http://www.ideaconnection.com/images/inventions/lg_wearable-artificial-kidney.jpg
http://www.mc3corp.com/images/content/sidebar_images/Professional_BioLung_drawin.jpg
What Is a Total Artificial Heart? . Total Artificial Heart. Retrieved November 18, 2009, from
http://www.nhlbi.nih.gov/health/dci/Diseases/tah/tah_what.html
Update on Work on Artificial Lung Prototypes - Regenerative Medicine at the McGowan Institute. Regenerative Medicine at the
McGowan Institute. Retrieved November 19, 2009, from http://www.mirm.pitt.edu/news/article.asp?qEmpID=266
Type 1 Diabetes. University of Virginia Health System. Retrieved December 1, 2009, from
http://www.healthsystem.virginia.edu/uvahealth/adult_diabetes/type1.cfm
People Like Us Live Web Series. (National Kidney Foundation. Retrieved December 1, 2009, from
http://www.kidney.org/patients/plu/plu_hemo/pluo_3.cfm
MC3 Artificial Lung (Biolung). MC3 Artificial Lung (Biolung). Retrieved December 1, 2009, from
:www.ele.uri.edu/courses/ele382/F07/Afeez_1.pdf
End Stage Renal Disease (ESRD). University of Virginia Health System. Retrieved December 1, 2009, from
http://www.healthsystem.virginia.edu/UVAHealth/adult_urology/endstage.cfm
Artificial Pancreas - iVillage Your Total Health. iVillage Your Total Health Home - iVillage Your Total Health. Retrieved
December 1, 2009, from http://lymphomafocus.org/artificial-pancreas.html?pageNum=3
Artificial Heart Program Technology - Pulsatile Systems - Regenerative Medicine at the McGowan Institute. (n.d.). Regenerative
Medicine at the McGowan Institute. Retrieved December 1, 2009, from
http://www.mirm.pitt.edu/programs/medical_devices/ahp_technology3.asp
18